Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Cataract; and very common findings: Reduced visual acuity. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Cataract, Pendular nystagmus, Amblyopia |
Age of onset: at birth.
DNMBP encodes dynamin binding protein (1,577 aa). Plays a critical role as a guanine nucleotide exchange factor (GEF) for CDC42 in several intracellular processes associated with the actin and microtubule cytoskeleton. Highest expression in Skin Sun Exposed Lower leg (33.6 TPM) and Skin Not Sun Exposed Suprapubic (32.9 TPM).
Cataract 48 is associated with mutations in the DNMBP gene on chromosome 10.
The DNMBP protein participates in RHOJ GEFs activate RHOJ, RHOQ GEFs activate RHOQ, and RHOC GEFs activate RHOC pathways.
DNMBP is classified as a druggable target with score 0.0.
Genetic testing for DNMBP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cataract 48 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 very common feature, 2 common features.
No clinical trials have been registered for cataract 48.
202 publications have been identified in PubMed for cataract 48. Kisho has analyzed 52 by research type. Research spans Epidemiology / Natural History (44%), Review / Meta-Analysis (19%), and Clinical Trial Publication (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 23 | 44% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 7:09 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about cataract 48
Research summaries
10 |
19% |
Clinical study results | 10 | 19% |
Laboratory research | 4 | 8% |
Testing and diagnosis research | 3 | 6% |
Patient case studies | 2 | 4% |
de Jong B (2026). [PMID: 41424410](https://pubmed.ncbi.nlm.nih.gov/41424410/). *Curr Eye Res*. [Basic Science / Preclinical]
Ben Abid A (2025). [PMID: 39812198](https://pubmed.ncbi.nlm.nih.gov/39812198/). *Tunis Med*. [Diagnostic / Biomarker]
Tahiri R (2025). [PMID: 39520826](https://pubmed.ncbi.nlm.nih.gov/39520826/). *J Fr Ophtalmol*. [Review / Meta-Analysis]
Lee JS (2025). [PMID: 40738332](https://pubmed.ncbi.nlm.nih.gov/40738332/). *Ophthalmology*. [Epidemiology / Natural History]
Jue Z (2025). [PMID: 39179900](https://pubmed.ncbi.nlm.nih.gov/39179900/). *Graefes Arch Clin Exp Ophthalmol*. [Review / Meta-Analysis]
Lakhani M (2025). [PMID: 40505686](https://pubmed.ncbi.nlm.nih.gov/40505686/). *Can J Ophthalmol*. [Epidemiology / Natural History]
Baiad AA (2025). [PMID: 39842716](https://pubmed.ncbi.nlm.nih.gov/39842716/). *Ophthalmol Retina*. [Review / Meta-Analysis]
Jindal DA (2025). [PMID: 40965862](https://pubmed.ncbi.nlm.nih.gov/40965862/). *JAMA Ophthalmol*. [Epidemiology / Natural History]
Espino-Guarch M (2025). [PMID: 40546137](https://pubmed.ncbi.nlm.nih.gov/40546137/). *J Cachexia Sarcopenia Muscle*. [Basic Science / Preclinical]
Peng Y (2025). [PMID: 40781300](https://pubmed.ncbi.nlm.nih.gov/40781300/). *BMC Med*. [Epidemiology / Natural History]